Nathan Rice
Stock Analyst at Piper Sandler
(2.77)
# 2,003
Out of 5,006 analysts
56
Total ratings
45.71%
Success rate
8.37%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBIN Merchants Bancorp | Maintains: Overweight | $42 → $41 | $32.32 | +26.86% | 8 | Jul 30, 2025 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $47 → $49 | $37.67 | +30.08% | 4 | Jul 28, 2025 | |
| BFC Bank First | Maintains: Neutral | $115 → $137 | $133.06 | +2.96% | 8 | Jul 21, 2025 | |
| BY Byline Bancorp | Reiterates: Overweight | $34 | $28.15 | +20.78% | 8 | Oct 29, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $76.84 | -3.70% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $135.29 | -37.91% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $131.50 | +49.81% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $20.68 | -56.48% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $627.78 | -30.71% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $302.99 | -23.10% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $37.64 | +120.51% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $17.52 | -14.38% | 1 | Dec 19, 2019 |
Merchants Bancorp
Jul 30, 2025
Maintains: Overweight
Price Target: $42 → $41
Current: $32.32
Upside: +26.86%
First Mid Bancshares
Jul 28, 2025
Maintains: Overweight
Price Target: $47 → $49
Current: $37.67
Upside: +30.08%
Bank First
Jul 21, 2025
Maintains: Neutral
Price Target: $115 → $137
Current: $133.06
Upside: +2.96%
Byline Bancorp
Oct 29, 2024
Reiterates: Overweight
Price Target: $34
Current: $28.15
Upside: +20.78%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $76.84
Upside: -3.70%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $135.29
Upside: -37.91%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $131.50
Upside: +49.81%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $20.68
Upside: -56.48%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $627.78
Upside: -30.71%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $302.99
Upside: -23.10%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $37.64
Upside: +120.51%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $17.52
Upside: -14.38%